March 19 (Reuters) - Simris Group AB SIMRISb.ST:
SIMRIS EVALUATING OPTIONS TO EXPAND ITS ADC-PAYLOAD DEVELOPMENT PROGRAMME AND PREPARE FOR THE NEXT FUNDING ROUND TO ACCELERATE ITS PLANS.
BOARD EVALUATING TWO STRATEGIC OPTIONS REQUIRING ADDITIONAL FUNDING
CONSIDERS CONTINUED PRE-CLINICAL DEVELOPMENT OF MICROCYSTIN-ADC PLATFORM
CONSIDERS INTEGRATION OF ADC TEAM AND CLINICALLY VALIDATED PAYLOAD CLASS
Source text: ID:nMFN2FGGxB
Further company coverage: [SIMRISb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))